| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/08/2009 | US20090010954 Prevention and treatment of sub-clinical pcvd |
| 01/08/2009 | US20090010951 Epitope/Peptide Recognized By Hla-A2402-Restricted Ep/Cam-Specific Ctl And Use Of The Same |
| 01/08/2009 | US20090010947 Red Microalgae Expressing Exogenous Polypeptides And Methods Of Generating And Utilizing Same |
| 01/08/2009 | US20090010946 Novel Stromal Cell-Derived Factor-1 Polypeptides, Polynucleotides, Modulators Thereof and Methods of Use |
| 01/08/2009 | US20090010945 conjugating drug to antibody by reducing antibody with reducing agent, treating antibody with reoxidizing agent to reform interchain disulfide bond of antibody to form partially reoxidized antibody such that two cysteine thiols remain, conjugating drug to interchain thiol of antibody via maleimide group |
| 01/08/2009 | US20090010944 Oligosialic acid derivatives, methods of manufacture, and immunological uses |
| 01/08/2009 | US20090010941 Methods for treating HIV |
| 01/08/2009 | US20090010938 Short immunomodulatory oligonucleotides |
| 01/08/2009 | US20090010936 Novel Stra6 Polypeptides |
| 01/08/2009 | US20090010932 Gb virus c (hepatitis g virus) for the treatment of hiv |
| 01/08/2009 | US20090010931 restoring growth inhibition sensitivity to a tumor cell resistant to growth inhibition by HER2 antagonists; antibody produced by the hybridoma 4F10; PC-Cell Derived Growth Factor (PCDGF) |
| 01/08/2009 | US20090010929 Therapeutic Antibodies, Antibody Fragments and Antibody Conjugates |
| 01/08/2009 | US20090010928 Anti-anthrax antibody, formulations thereof, and methods of use |
| 01/08/2009 | US20090010917 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor |
| 01/08/2009 | US20090010907 Dnazymes for Inhibition of Japanese Encephalitis Virus Replication |
| 01/08/2009 | US20090010880 2-Amino-2,7-dideoxy-alpha-D-glycero-D-gluco-heptopyranosyl Inhibitors of Positive Sense Single-Stranded RNA Envelope Viruses |
| 01/08/2009 | US20090010875 IL-7 Fusion Proteins |
| 01/08/2009 | US20090010840 BISPECIFIC SINGLE CHAIN Fv ANTIBODY MOLECULES AND METHODS OF USE THEREOF |
| 01/08/2009 | DE102007031397A1 Verwendung von Deuteriumoxid zur Behandlung von Virus-basierten Erkrankungen der Haut Use of deuterium oxide in the treatment of virus-based diseases of the skin |
| 01/08/2009 | CA2722015A1 Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activity |
| 01/08/2009 | CA2699965A1 Pet probe having an alkoxy group substituted by fluorine and hydroxy group |
| 01/08/2009 | CA2692478A1 Treatment of influenza |
| 01/08/2009 | CA2692460A1 Novel hiv reverse transcriptase inhibitors |
| 01/08/2009 | CA2692260A1 Macrolactone derivatives |
| 01/08/2009 | CA2692101A1 Combination of 6-(3-chloro-2-fluorobenzyl)-1-[(2s)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid and a compound that inhibits a ugt pathway or ugt metabolism |
| 01/08/2009 | CA2691954A1 Novel 4-{3-[4-(3-{4-[amino(butoxycarbonylimino)methyl]phenoxy}propyl)-1-piperidinyl]propoxy}-n'-(butoxycarbonyl) benzamidine crystals |
| 01/08/2009 | CA2691807A1 Stereoisomers of tricyclodecan-9-yl-xanthogenate |
| 01/08/2009 | CA2691736A1 Combination of 6-(3-chloro-2-fluorobenzyl)-1-[(2s)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid and lopinavir for the treatment of a viral infection in a human |
| 01/08/2009 | CA2691626A1 Pseudomonas aeruginosa-outer membrane protein pa4710 |
| 01/08/2009 | CA2691444A1 Purine derivatives and their use as modulators of toll-like receptor 7 |
| 01/08/2009 | CA2681813A1 Transcription factor modulating compounds and methods of use thereof |
| 01/07/2009 | EP2011889A1 Methods for measuring drug resistance against HCV |
| 01/07/2009 | EP2011888A1 Nucleotide sequences resulting from the genome of the HIV-1, HIV-2 and SIV retroviruses, and their applications in particular for amplifying the genomes of these retroviruses and for in vitro diagnosis of infections caused by these viruses |
| 01/07/2009 | EP2011877A2 Conjugates for the modulation of immune responses |
| 01/07/2009 | EP2011876A1 Dna vaccine for koi herpes virus (khv) disease |
| 01/07/2009 | EP2011874A1 Recombinant gelatin in vaccines |
| 01/07/2009 | EP2011862A1 Method for manufacturing an active component of a medicine or diagnosis agent in MDCJ cell suspension culture |
| 01/07/2009 | EP2011800A2 Inhibitors of caspase |
| 01/07/2009 | EP2011512A1 An anti HSP90 antibody |
| 01/07/2009 | EP2011510A2 Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments |
| 01/07/2009 | EP2011509A2 Pharmaceutical composition containing the nmb0606 protein |
| 01/07/2009 | EP2011508A1 Use of trap protein as active ingredient for manufacturing a medicament for the treatment of staphylococcus aureus infection |
| 01/07/2009 | EP2011489A2 Method to inhibit ischemia and reperfusion injury |
| 01/07/2009 | EP2010561A1 Antimicrobial peptides |
| 01/07/2009 | EP2010553A1 Substituted adenines and the uses thereof |
| 01/07/2009 | EP2010532A1 Tryclic nitrogen containing compounds and their use as antibacterials |
| 01/07/2009 | EP2010525A2 Diketo-piperazine and piperidine derivatives as antiviral agents |
| 01/07/2009 | EP2010511A1 Chromen-2-one derivatives |
| 01/07/2009 | EP2010220A2 Stabilized pentosan polysulfate (pps) formulations and methods of analyzing them |
| 01/07/2009 | EP2010202A2 Novel antibacterial compounds |
| 01/07/2009 | EP2010201A1 Hcv vaccinations |
| 01/07/2009 | EP1890681B1 Dry granulated composition comprising emtricitabine and tenofovir DF |
| 01/07/2009 | EP1751155B1 Substituted azachinazolines having an antiviral action |
| 01/07/2009 | EP1503737B1 Nanoparticulate nystatin formulations |
| 01/07/2009 | EP1470113B1 Pyrimidinone viral polymerase inhibitors |
| 01/07/2009 | EP1431285B1 Reverse hydroxamic acid derivatives |
| 01/07/2009 | EP1407008B1 Influenza vaccine composition |
| 01/07/2009 | EP1392662B1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments |
| 01/07/2009 | EP1357909B1 Il-8 receptor antagonists |
| 01/07/2009 | EP1317559B1 Dna transfection system for the generation of infectious negative strand rna virus |
| 01/07/2009 | EP1311538B1 Inhibitors of hiv replication and method of treatment of hiv infections |
| 01/07/2009 | EP1309348B1 Prophylactic and therapeutic monoclonal antibodies against vaccinia virus antigens |
| 01/07/2009 | EP1223973B1 Method of expressing antigens on the surface of antigen presenting cells by photochemical internalization |
| 01/07/2009 | EP1204665B1 Chemokine receptor antagonists and methods of use therefor |
| 01/07/2009 | EP1204425B1 Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein |
| 01/07/2009 | EP1127065B1 Chlamydia antigen and corresponding dna fragments and uses thereof |
| 01/07/2009 | EP1012293B1 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| 01/07/2009 | EP0980389B1 Antigen |
| 01/07/2009 | EP0870046B1 Recombinant live vaccine containing feline herpes virus type 1, particularly for treating feline infectious peritonitis |
| 01/07/2009 | CN101341160A Process for production of water-soluble azole prodrug |
| 01/07/2009 | CN101341150A Nitroimidazole compounds |
| 01/07/2009 | CN101341135A Novel substituted pyrazinone derivatives for use in MCH-1 mediated diseases |
| 01/07/2009 | CN101340918A Alkyl phospholipid derivatives with reduced cytotoxicity and uses thereof |
| 01/07/2009 | CN101340917A Methods of treating gastrointestinal tract infections with tigecycline |
| 01/07/2009 | CN101340902A Materials and methods for treating viral infections with a cysteamine compound |
| 01/07/2009 | CN101340895A Oral formulations comprising tigecycline |
| 01/07/2009 | CN101340890A Denaturant for ethanol |
| 01/07/2009 | CN101338004A Sterilization polymer and preparation process thereof |
| 01/07/2009 | CN101337990A Humanized neutralizing antibody against rabies virus, method for preparing same and use |
| 01/07/2009 | CN101337971A Method for synthesizing antibiotic cefepime hydrochloride |
| 01/07/2009 | CN101337970A Method for synthesizing antibiotic cefpirome sulfate |
| 01/07/2009 | CN101337969A Synthetic method of antibiotic cefixime |
| 01/07/2009 | CN101337948A 1,5-benzothiazepines compounds, preparation method and application thereof |
| 01/07/2009 | CN101337916A Florfeniol sulfonic acid ester, salt thereof and method for preparing same |
| 01/07/2009 | CN101337070A Freeze-dried attenuated live vaccine for hepatitis A and its preparing process |
| 01/07/2009 | CN101337069A Compound plague vaccine and preparation method thereof |
| 01/07/2009 | CN101337054A Canine parvovirus prevention preparation |
| 01/07/2009 | CN101337053A Traditional Chinese medicine for treating pestilence and production method thereof |
| 01/07/2009 | CN101337049A Production method of pills for treating rheumatoid, rheumatism and infantile paralysis |
| 01/07/2009 | CN101337040A Gynecology lotion |
| 01/07/2009 | CN101337035A Traditional Chinese preparation with bacteriostatic action for preventing blood sugar rising and preparation method thereof |
| 01/07/2009 | CN101337033A Canine parvovirus resisting preparation |
| 01/07/2009 | CN101337015A Traditional Chinese medicine for gynecology and dermatology and preparation method thereof |
| 01/07/2009 | CN101337011A Traditional Chinese medicine formulation for treating herpes circunata |
| 01/07/2009 | CN101337007A Ointment for treating beriberi |
| 01/07/2009 | CN101336994A Houttuynia instant gel for eye |
| 01/07/2009 | CN101336991A Medicine for treating gynaecologic pruritus vulvae and colpitis |
| 01/07/2009 | CN101336987A Preparation method of total flavone of Hovenia dulcisThunb |
| 01/07/2009 | CN101336979A Liquid medicine for ordinary wound |
| 01/07/2009 | CN101336976A Oral traditional Chinese medicine formulation for treating genital herpes and preparation method thereof |